These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 8295192

  • 1. Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis.
    Wallace CA, Smith AL, Sherry DD.
    J Rheumatol; 1993 Oct; 20(10):1764-8. PubMed ID: 8295192
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM.
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [Abstract] [Full Text] [Related]

  • 3. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis.
    Ravelli A, Viola S, Ramenghi B, Aramini L, Ruperto N, Martini A.
    J Rheumatol; 1995 Aug; 22(8):1574-6. PubMed ID: 7473486
    [Abstract] [Full Text] [Related]

  • 4. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis.
    Wallace CA, Sherry DD.
    J Rheumatol; 1992 Oct; 19(10):1604-7. PubMed ID: 1464876
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M, Booth J, Loxton A, McCarthy P, Meffin P, Kevat S.
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
    Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate.
    Balsa A, Gamallo C, Martín-Mola E, Gijón-Baños J.
    J Rheumatol; 1993 Sep; 20(9):1472-7. PubMed ID: 8164201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
    Skeith KJ, Russell AS, Jamali F, Coates J, Friedman H.
    J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate in the treatment of children with chronic arthritis--long-term observations of efficacy and safety.
    Huang JL.
    Br J Clin Pract; 1996 Sep; 50(6):311-4. PubMed ID: 8983319
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
    Hunt PG, Rose CD, McIlvain-Simpson G, Tejani S.
    J Rheumatol; 1997 Nov; 24(11):2230-2. PubMed ID: 9375889
    [Abstract] [Full Text] [Related]

  • 16. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate.
    Rooney TW, Furst DE, Koehnke R, Burmeister L.
    J Rheumatol; 1993 Aug; 20(8):1297-302. PubMed ID: 8230008
    [Abstract] [Full Text] [Related]

  • 17. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Reiff A, Rawlings DJ, Shaham B, Franke E, Richardson L, Szer IS, Bernstein BH.
    J Rheumatol; 1997 Dec; 24(12):2436-43. PubMed ID: 9415655
    [Abstract] [Full Text] [Related]

  • 18. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
    Masi L, Ricci L, Zulian F, Del Monte F, Simonini G, Capannini S, De Martino M, Brandi ML, Falcini F.
    J Rheumatol; 2009 Oct; 36(10):2308-13. PubMed ID: 19684155
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K, Cevallos WH, DeCleene SA, Korth-Bradley JM.
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.